Torrent Pharma acquires four brands from Dr Reddy’s
The integration and transition of the brands are expected to be completed by June 2022.
The integration and transition of the brands are expected to be completed by June 2022.
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
The AI and technology upgrades allow doctors to choose their medical speciality and even spelling preferences to set their own speech model
ICICI Direct expects revenue CAGR of 35.6% over FY22-FY24E mainly due to the consolidation of Viatris business and they expect EBITDA margin expansion of 230bps and earnings CAGR of 64.8% over FY22-FY24E
For the third straight year, Lumenis wins an award recognizing outstanding medical companies and technologies
The new facility at Dombivli is the fifth ASG Eye Hospital in Maharashtra
By 2025, the company plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry
The company has posted net profit of Rs.605.05 crores for the Financial Year ended March 31, 2022
The two-year agreement will grant Lonza access to IBF's prominent network and allow IBF to benefit from Lonza's manufacturing expertise and knowledge in its due diligence review of potential targets
The new advanced regional processing lab will serve Nagpur city and the Vidarbha region
Subscribe To Our Newsletter & Stay Updated